论文信息 - Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial - 字舞流文

Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

P. Libby | P. Pais | J. Varigos | P. Ridker | R. Glynn | K. Seung | M. Flather | A. Budaj | J. Kastelein | W. Koenig | C. Ballantyne | J. Cornel | P. Sinnaeve | R. Cífková | M. Donath | H. Shimokawa | D. Pella | N. Gotcheva | M. Dellborg | D. Miličić | A. Fucili | J. Nicolau | H. Ogawa | P. Commerford | A. Manolis | S. Bilazarian | F. Fonseca | J. Genest | A. Lorenzatti | M. Urina-Triana | Juey-Jen Hwang | Z. Kobalava | F. Wyss | A. Sigurdsson | P. Otasevic | T. Forster | F. Medina | Brendan M. Everett | T. Klemsdal | T. Thuren | C. East | P. Siostrzonek | H. Kultursay | B. Petrauskiene | L. Vida-Simiti | M. Ligueros | William Chang | S. Anker | L. Forgosh | Huo Yong | R. Vettus | I. Veze | Leon Salvador | Barry Harris | M. Lainščak | Jean G Macfadyen | Prem Pais